May 27pokeryoutubeHengrui Pharmaceutical issued an announcement saying that recently, the company's subsidiaries Shanghai Hengrui Pharmaceutical Co., Ltd. and Suzhou Shengdiya Biomedical Co., Ltd. received approval from the State Food and Drug Administration for the issuance of SHR-9839 for injection, SHR-A1921 for injection and SHR-A2009 for injectionpokeryoutubeThe Drug Clinical Trial Approval Notice will be launched in the near future.
